RSPO1 Protein
Quick Overview for RSPO1 Protein (ABIN2731226)
Target
See all RSPO1 ProteinsProtein Type
Biological Activity
Origin
Source
Application
Purity
-
-
Specificity
- Optimal preservation of protein structure, post-translational modifications and functions.
-
Characteristics
-
- Recombinant human RSPO1 protein expressed in CHO cells.
- Produced with end-sequenced ORF clone
- Tested for bioactivity.
-
Endotoxin Level
- Endotoxin level is <0.1 ng/μg of protein (<1EU/μg).
-
Biological Activity Comment
- R-spondin-1 enhances BMP-2 mediated differentiation of MC3T3-E1 cells. The expected ED50 is 1.0-3.0 ug/ml.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays
Protein-protein interaction
In vitro biochemical assays and cell-based functional assays -
Restrictions
- For Research Use only
-
-
-
Buffer
- Lyophilized from a 0.2 μM filtered solution of 20 mM phosphate buffer,100 mM NaCl, pH 7.2
-
Handling Advice
- Resuspend the protein in the desired concentration in proper buffer
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- RSPO1 (R-Spondin 1 (RSPO1))
-
Alternative Name
- Rspo1
-
Background
- This gene encodes a secreted activator protein with two cysteine-rich, furin-like domains and one thrombospondin type 1 domain. The encoded protein is a ligand for leucine-rich repeat-containing G-protein coupled receptors (LGR proteins) and positively regulates the Wnt signaling pathway. In mice, the protein induces the rapid onset of crypt cell proliferation and increases intestinal epithelial healing, providing a protective effect against chemotherapy-induced adverse effects. Alternative splicing results in multiple transcript variants.
-
Molecular Weight
- 26.7 kDa
-
NCBI Accession
- NP_001033722
Target
-